產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-Bivalirudin抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢(xún)訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-Bivalirudin抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Bivalirudin
Cat. Number:
Anti-Bivalirudin抗體KL-4561R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Bivalirudin is a specific and reversible direct thrombin inhibitor (DTI). Chemically, it is a synthetic congener of the naturally Anti-Bivalirudin抗體occurring drug hirudin (found in the saliva of the medicinal leech Hirudo medicinalis). Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin. It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life. It does not bind to plasma proteins (other than thrombin) or to red blood cells. Therefore, it has a predictable antithrombotic response. There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS). It does not require a binding cofactor such as antithrombin and does not activate platelets. These characteristics Anti-Bivalirudin抗體make bivalirudin an ideal alternative to heparin.
Also known as:
Bivalirudin; 128270-60-0
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Hirudin.Anti-Bivalirudin抗體
●
Immunogen: KLH conjugated synthetic peptide Bivalirudin (d-FPRPGGGGNGDFEEIPEEYL).
●
Predicted Molecular Weight: 2.108kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-Bivalirudin抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-Bivalirudin抗體must be determined by the end user.
kl137Hu01 ⅩⅤ型膠原(COL15)多克隆抗體 Polyclonal Antibody to Collagen Type XV (COL15)
kl137Mu01 ⅩⅤ型膠原(COL15)多克隆抗體 Polyclonal Antibody to Collagen Type XV (COL15)
kl138Hu01 ⅩⅢ型膠原(COL13)多克隆抗體 Polyclonal Antibody to Collagen Type XIII (COL13)
kl143Hu01 Ⅳ型膠原α3(COL4α3)多克隆抗體 Polyclonal Antibody to Collagen Type IV Alpha 3 (COL4a3)
kl145Ra01 Ⅸ型膠原α1(COL9α1)多克隆抗體 Polyclonal Antibody to Collagen Type IX Alpha 1 (COL9a1)
kl146Hu01 Ⅷ型膠原α1(COL8α1)多克隆抗體 Polyclonal Antibody to Collagen Type VIII Alpha 1 (COL8a1)
kl147Hu01 Ⅶ型膠原(COL7)多克隆抗體 Polyclonal Antibody to Collagen Type VII (COL7)
kl147Mu01 Ⅶ型膠原(COL7)多克隆抗體 Polyclonal Antibody to Collagen Type VII (COL7)
kl148Hu01 Ⅵ型膠原α3(COL6α3)多克隆抗體 Polyclonal Antibody to Collagen Type VI Alpha 3 (COL6a3)
kl150Hu01 Ⅵ型膠原α1(COL6α1)多克隆抗體 Polyclonal Antibody to Collagen Type VI Alpha 1 (COL6a1)
kl150Mu01 Ⅵ型膠原α1(COL6α1)多克隆抗體 Polyclonal Antibody to Collagen Type VI Alpha 1 (COL6a1)
kl152Hu01 Ⅴ型膠原α2(COL5α2)多克隆抗體 Polyclonal Antibody to Collagen Type V Alpha 2 (COL5a2)
kl152Mu01 Ⅴ型膠原α2(COL5α2)多克隆抗體 Polyclonal Antibody to Collagen Type V Alpha 2 (COL5a2)
kl155Hu01 Ⅸ型膠原α3(COL9α3)多克隆抗體 Polyclonal Antibody to Collagen Type IX Alpha 3 (COL9a3)
kl156Hu01 Ⅹ型膠原(COL10)多克隆抗體 Polyclonal Antibody to Collagen Type X (COL10)
kl156Mu01 Ⅹ型膠原(COL10)多克隆抗體 Polyclonal Antibody to Collagen Type X (COL10)
kl156Ra01 Ⅹ型膠原(COL10)多克隆抗體 Polyclonal Antibody to Collagen Type X (COL10)
kl157Hu01 Ⅺ型膠原α1(COL11α1)多克隆抗體 Polyclonal Antibody to Collagen Type XI Alpha 1 (COL11a1)
kl158Hu01 Ⅻ型膠原(COL12)多克隆抗體 Polyclonal Antibody to Collagen Type XII (COL12)
kl158Mu01 Ⅻ型膠原(COL12)多克隆抗體 Polyclonal Antibody to Collagen Type XII (COL12)
